Glycogen Storage Disease IB: Clinical Trials

7 trials for Glycogen Storage Disease IB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Glycogen Storage Disease IB: new trials by email Literature Review of Glycogen Storage Disease IB trials Research Report on Glycogen Storage Disease IB

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of the Carbohydrate Counting Method on Blood Glucose Regulation, Quality of Life, Urinary Glc4 and Other Biomarkers in Children With GSD1
Glycogen Storage Disease Type I, Glycogen Storage Disease Type IB
Not yet recruitingŞükrü Arman AKSOY82026-10-302026-10-15
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
Lactate Meter, Accu Chek - Glycogen Storage Disease Type IA, Glycogen Storage Disease Type I
RecruitingConnecticut Children's Medical Center102026-08-012026-06-01
Efficacy and Safety of Empagliflozin in GSD-Ib Patients
Empagliflozin - Glycogen Storage Disease Type IB
Phase 2WithdrawnXinhua Hospital, Shanghai Jiao Tong University School of Medicine2023-07-152026-06-18
Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)
Specimen Donation - Glycogen Storage Disease Type IB
TerminatedSanguine Biosciences62023-04-272024-04-19
Prospective Cohort Study of Children With GSD1b Receiving Empagliflozin
Empagliflozin - Glycogen Storage Disease Type IB
UnknownHong Kong Children's Hospital112021-08-082021-08-16
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch
Glycosade - Glycogen Storage Disease Type IA, Glycogen Storage Disease Type IB
CompletedJohn Mitchell112013-11-012015-09-25

Narrower conditions

Glycogen Storage Disease Type I (3)  ·  Hepatorenal form of glycogen storage disease (3)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)  ·  3-Hydroxyacyl-CoA Dehydrogenase Deficiency (1)  ·  3-methylcrotonyl CoA carboxylase 1 deficiency (1)  ·  3-methylcrotonyl CoA carboxylase 2 deficiency (1)  ·  Acidemia, isovaleric (1)  ·  Acrodermatitis enteropathica (1)  ·  Adenine phosphoribosyltransferase deficiency (1)  ·  Adrenal hyperplasia, congenital, type 5 (1)  ·  Adrenocorticotropic hormone deficiency (1)  ·  Amaurosis congenita of Leber, type 2 (1)  ·  Anemia, Sickle Cell (1)  ·  Angelman Syndrome (1)

Broader conditions

Carbohydrate Metabolism, Inborn Errors (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Metabolic Diseases (4)  ·  Metabolism, Inborn Errors (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Glycogen Storage Disease (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Renal Tubular Transport, Inborn Errors (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Abnormalities, Multiple (1)

Interventions

empagliflozin (2)

Sponsors

Connecticut Children's Medical Center (1)  ·  Hong Kong Children's Hospital (1)  ·  John Mitchell (1)  ·  RTI International (1)  ·  Sanguine Biosciences (1)  ·  Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)  ·  Şükrü Arman AKSOY (1)

Countries

United States (3)  ·  Canada (1)  ·  China (1)  ·  Hong Kong (1)  ·  Turkey (Türkiye) (1)

Top investigators

Curt Scharfe, MD, PhD (1)  ·  John J Mitchell, MD (1)  ·  Malaya Mount, MS, RD, CDN (1)  ·  Mei Kwun Kwok (1)  ·  Rebecca Riba-Wolman, MD (1)  ·  Wenjuan Qiu, MD PhD (1)

Results publications

PMID 31315600, PMID 35142618